Cannabis is still considered a Schedule I drug in the United States, which means it is classified as having a high potential for abuse and no accepted medical use. This classification can make it difficult to market cannabis products to the masses, as it is seen as an illicit drug in the eyes of many. Furthermore, cannabis products are subject to strict regulations, which can make it difficult to advertise and market them in certain areas. Despite the challenges, there are still a growing number of companies that are devoted to producing and marketing cannabis products. These companies must be mindful of the regulations and work to make sure their products are safe and compliant. Ultimately, the stigma surrounding cannabis products will continue to be a challenge, but with proper care and consideration, cannabis products can be marketed to the masses.